Gilead Sciences Inc and Merck & Co Inc have temporarily paused enrollment in the Phase 2 study evaluating the combination regimen of islatravir and lenacapavir in HIV infection. The temporary pause ...
网页链接Gilead Sciences Inc and Merck & Co Inc have temporarily paused enrollment in the Phase 2 study evaluating the combination regimen of islatravir and lenacapavir in HIV infection. The temporary pause ...
网页链接
精彩评论